Provided by Tiger Trade Technology Pte. Ltd.

Greenwich Lifesciences Inc

26.11
-0.0200-0.08%
Volume:60.46K
Turnover:1.54M
Market Cap:361.74M
PE:-17.88
High:26.60
Open:25.85
Low:24.75
Close:26.13
52wk High:34.10
52wk Low:7.78
Shares:13.85M
Float Shares:6.37M
Volume Ratio:1.06
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4606
EPS(LYR):-1.2132
ROE:-543.43%
ROA:-254.19%
PB:165.56
PE(LYR):-21.52

Loading ...

Greenwich LifeSciences CEO and CFO Snehal Patel Reports Acquisition of Common Shares

Reuters
·
Jan 02

Greenwich LifeSciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 30, 2025

Greenwich Lifesciences, Inc. : H.c. Wainwright Raises Target Price to $50 From $39

THOMSON REUTERS
·
Dec 30, 2025

Greenwich LifeSciences Up Nearly 45%, on Pace for Largest Percent Increase Since March 2021 -- Data Talk

Dow Jones
·
Dec 30, 2025

BRIEF-Greenwich LifeSciences Extends Lock-Up Of Shares To September 2026

Reuters
·
Dec 29, 2025

Greenwich LifeSciences Extends Share Lock-Up to September For Directors, Officers

MT Newswires Live
·
Dec 29, 2025

Greenwich Lifesciences Inc - Officers and Directors Cannot Sell Shares During Lock-up

THOMSON REUTERS
·
Dec 29, 2025

Greenwich LifeSciences Extends Lock-Up to Support Phase III Breast Cancer Immunotherapy Trial

Reuters
·
Dec 29, 2025

What's Going On With Greenwich LifeSciences Friday?

Benzinga_recent_news
·
Dec 27, 2025

Greenwich Lifesciences Outlines Plans to Expand FLAMINGO-01 Trial Sites, Reduce Costs, Pursue Additional Patent Filings, and Advance Partnering Strategy for GLSI-100

Reuters
·
Dec 22, 2025

Greenwich Lifesciences Provides Additional Updates on Flamingo-01 and Corporate Strategy

THOMSON REUTERS
·
Dec 22, 2025

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy

GlobeNewswire
·
Dec 22, 2025

Greenwich Lifesciences Inc. held annual shareholder meeting

Reuters
·
Dec 19, 2025

Greenwich Lifesciences Reports 80% Reduction in Breast Cancer Recurrence in FLAMINGO-01 Trial

Reuters
·
Dec 15, 2025

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01

GlobeNewswire
·
Dec 08, 2025

BRIEF-Greenwich Lifesciences Provides Global Update On Flamingo-01

Reuters
·
Dec 03, 2025

Greenwich Lifesciences Provides Global Update on Flamingo-01, Screening Over 1,000 Patients to Date

THOMSON REUTERS
·
Dec 03, 2025

Top Executive Makes Bold Move with Major Stock Purchase

TIPRANKS
·
Nov 29, 2025

Greenwich LifeSciences CEO and CFO Snehal Patel Acquires Common Shares

Reuters
·
Nov 28, 2025

Greenwich Lifesciences CEO and CFO Snehal Patel Reports Acquisition of Common Shares

Reuters
·
Nov 12, 2025